- Home
- SNY vs FI Comparison
SNY vs FI Comparison
Compare SNY & FI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- FI
- Stock Information
- Founded
- SNY 1994
- FI 1984
- Country
- SNY France
- FI United States
- Employees
- SNY N/A
- FI N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- FI Business Services
- Sector
- SNY Health Care
- FI Consumer Discretionary
- Exchange
- SNY Nasdaq
- FI Nasdaq
- Market Cap
- SNY 134.4B
- FI 120.2B
- IPO Year
- SNY N/A
- FI 1986
- Fundamental
- Price
- SNY $54.46
- FI $232.41
- Analyst Decision
- SNY Strong Buy
- FI Strong Buy
- Analyst Count
- SNY 1
- FI 25
- Target Price
- SNY $60.00
- FI $237.96
- AVG Volume (30 Days)
- SNY 2.4M
- FI 2.9M
- Earning Date
- SNY 01-30-2025
- FI 02-05-2025
- Dividend Yield
- SNY 4.04%
- FI N/A
- EPS Growth
- SNY 2.94
- FI 8.01
- EPS
- SNY 4.60
- FI 5.38
- Revenue
- SNY $45,849,466,833.00
- FI $20,456,000,000.00
- Revenue This Year
- SNY $9.02
- FI $4.85
- Revenue Next Year
- SNY $6.31
- FI $8.93
- P/E Ratio
- SNY $23.70
- FI $43.20
- Revenue Growth
- SNY 7.73
- FI 7.14
- 52 Week Low
- SNY $45.22
- FI $145.98
- 52 Week High
- SNY $58.97
- FI $238.00
- Technical
- Relative Strength Index (RSI)
- SNY 62.24
- FI 67.03
- Support Level
- SNY $53.46
- FI $226.35
- Resistance Level
- SNY $55.04
- FI $238.00
- Average True Range (ATR)
- SNY 0.70
- FI 4.23
- MACD
- SNY -0.09
- FI 0.56
- Stochastic Oscillator
- SNY 75.32
- FI 79.56
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
About FI Fiserv Inc.
Fiserv is a leading provider of core processing and complementary services, such as electronic funds transfer, payment processing, and loan processing, for US banks and credit unions, with a focus on small and midsize banks. Through the merger with First Data in 2019, Fiserv also provides payment processing services for merchants. About 10% of the company's revenue is generated internationally.